New Analytical Insights into Treatment of Chronic Diseases

Abstract

Over the past few decades, there has been substantial progress in the chemical analysis methods and techniques of pharmaceutical entities. The role of International Pharmacopoeias and guidelines has gained more prominence with even greater recognition and attention. Particularly, the focus on the development of biopharmaceuticals has increased over the past few years. Consequently, there is greater demand for most recent and advanced knowledge of analytical pharmaceutical chemistry among pharmacy students and analytical chemists. Efforts are being made across several laboratories on development of new and advanced analytical techniques in titration; chromatography, electrophoresis and spectroscopy as the number of officially validated method gradually increase. Pharmaceutica Analytica Acta has been focusing on publishing the most recent and trending research activities addressing the emerging analytical challenges in evaluation and characterization of pharmaceutical components through different stages of drug development including drug discovery as active raw molecule, different phases of clinical development, in finished product, manufacture as well as quality control. The current issue of Pharmaceutica Chemica Acta focuses on one natural drug component and chemically synthesizes analogues of tyrosine inhibitors and presents their characteristic structural and functional properties. These components have great potential in the treatment and cure of prevailing chronic disease such as Alzheimer’s disease and Cancer.